SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SYNTHETECH - NZYM -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (357)6/16/2001 1:08:34 PM
From: hmpa  Read Replies (1) | Respond to of 372
 
If they continue to push business model that was shown not to work neither for Synthetech nor for anyone else in the business (small company, narrow product offerings, high overhead, no technology barriers for competition to overcome), they will have to reprice these options several more times...



To: keokalani'nui who wrote (357)8/2/2001 12:54:56 PM
From: tuck  Read Replies (1) | Respond to of 372
 
Wilder,

If I am understanding it correctly, the option exchange program is a de facto resetting of top manangement's options to lower exercise prices. In my view, no, that is not good. It retains employees by rewarding them for sub par results. These guys have a couple more quarters to show me they can execute. If not, tax loss selling time.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News